Related by context. All words. (Click for frequent words.) 68 alvespimycin 68 orally bioavailable 67 small molecule tyrosine 66 XL# XL# 66 LymphoStat B TM 66 Factor VIIa 66 liposomal formulation 66 metaglidasen 66 reslizumab 66 KSP inhibitor 66 volociximab 65 PDE4 inhibitor 65 evaluating tivozanib 65 oral prodrug 65 PI3K/Akt pathway inhibitor 65 ARIKACE ™ 65 TBC# 65 PDE# inhibitors 65 Panzem R NCD 65 CCR9 antagonist 65 AEG# 65 PRT# 64 CYT# potent vascular disrupting 64 receptor tyrosine kinase inhibitor 64 XmAb 64 TOCOSOL Camptothecin 64 Aflibercept 64 Aplidin 64 JAK inhibitors 64 IMA# 64 VEGFR2 inhibitor 64 GRN# 64 Ceflatonin 64 systemically administered 64 isoform selective 64 leading oral taxane 64 HuMax CD4 64 radiation sensitizer 64 Presents Preclinical 64 non nucleoside inhibitor 63 multiple myeloma MM 63 human IgG1 monoclonal 63 BCR ABL inhibitors 63 JAK2 inhibitor 63 Nanobody 63 mertansine 63 inhaled formulation 63 HGS ETR1 mapatumumab 63 Sudhir Agrawal D.Phil 63 XL# anticancer compounds 63 OvaRex R 63 generation antisense 63 Troxatyl 63 EGFR TKI 63 CCR5 mAb 63 generation FBPase inhibitor 63 Angiocept 63 Archexin 63 initiate Phase 1b 63 HGS# 63 nucleoside analog 63 MAGE A3 ASCI 63 RH1 63 CytoFabTM 63 docetaxel Taxotere R 63 ficlatuzumab 63 HCV protease inhibitors 63 therapeutic monoclonal antibody 63 HCD# [002] 63 OMP #M# 63 Pimavanserin 63 targeted radiotherapeutic 63 dopamine partial agonist 63 LymphoStat B belimumab 63 Annamycin 63 CR# vcMMAE 63 anticoagulant reversing agent 63 Gleevec resistant 63 acyclovir Lauriad R 63 p# inhibitor 63 PSMA ADC 63 bardoxolone 62 including eniluracil ADH 62 SAR# [002] 62 hematological tumors 62 PEGylated Fab fragment 62 IMiDs ® 62 proteasome inhibitor 62 IMiDs R 62 JVRS 62 rxRNA 62 AMPK activators 62 novel therapeutic antibodies 62 Abiraterone acetate 62 Daclizumab 62 orally administered inhibitor 62 transgenically produced product 62 investigational humanized monoclonal antibody 62 INCB# [001] 62 TRC# 62 ADP receptor antagonist 62 HCV NS3 protease 62 epothilone 62 THR beta agonist 62 immunotherapeutic agent 62 Zoraxel 62 forodesine 62 Insegia 62 metastatic renal cell 62 sulfonylurea glimepiride 62 Phase Ib study 62 AAG geldanamycin analog 62 AERx ® 62 ZK EPO 62 Allovectin 7 62 epothilones 62 MEK inhibitors 62 Soliris eculizumab 62 vinca alkaloid 62 Begins Dosing 62 DCVax ® Brain 62 AKT inhibitor 62 drug conjugate 62 HSP# inhibitor 62 immunomodulatory therapy 62 IPL# 62 deforolimus 62 lintuzumab SGN 62 Aurora kinase inhibitor 62 Virulizin ® 62 Aurexis 61 XmAb ® 61 IAP inhibitors 61 PEGylated interferon 61 class mGluR5 inhibitor 61 Guanilib 61 ATL# [002] 61 MEK inhibitor 61 Nanobody ® 61 PORxin TM 61 GLPG# 61 gallium containing 61 pan HDAC inhibitor 61 factor TNF receptor 61 IAP inhibitor 61 beta 1a 61 Proxinium TM 61 relapsed leukemia 61 personalized immunotherapy 61 Onconase 61 SAR# [004] 61 Genasense ® 61 Behcet uveitis 61 PSN# [001] 61 Initiates Phase II 61 TTF Therapy 61 huC# DM4 61 amrubicin 61 selective androgen receptor modulator 61 UPLYSO 61 dasatinib Sprycel 61 selective orally bioavailable 61 omacetaxine mepesuccinate 61 intranasal formulation 61 EndoTAG TM 61 XYOTAX TM 61 oral talactoferrin 61 R#/MEM # 61 Mipomersen 61 nilotinib Tasigna ® 61 essential thrombocythemia ET 61 TELINTRA R 61 PSN# [002] 61 oral picoplatin 61 Kosan dependence 61 ganetespib 61 XL# XL# XL# 61 P#X# antagonist 61 HGS ETR1 61 Trofex 61 generation purine nucleoside 61 ospemifene 61 OncoVEX GM CSF 61 vidofludimus 61 hyaluronidase enzyme 61 TMC# [002] 61 PKC# 61 BRAF inhibitor 61 RGB # 61 gamma secretase inhibitor 61 Hedgehog inhibitor 61 Azedra TM 61 phase IIb clinical 61 RhuDex ® 61 fusion inhibitor 61 INS# [001] 61 TRACON Pharmaceuticals 61 Ostabolin C TM 61 Fc fusion protein 61 tyrosine kinase inhibitor TKI 61 antibody MAb 61 BrachySil TM 61 Xanafide 61 systemic RNAi therapeutic 61 antisense inhibitors 61 VELCADE melphalan 61 Panzem NCD 61 Anavex #-# 61 selective kinase inhibitor 61 CDK inhibitor 61 Reports Preclinical Data 61 OMP #R# 61 DU #b 61 DPX Survivac 61 ZOLINZA 61 Phase IIb clinical trials 61 CBLC# 61 vinorelbine tartrate 61 oral dihydropyrimidine dehydrogenase DPD 61 PD LID 61 peptidomimetic 61 peripherally acting 61 Ecallantide 61 ophthalmology dermatology cardiovascular disease 61 generation antisense inhibitor 61 investigational pan BCR 61 XL# XL# XL# XL# 61 OncoVEX 61 MT# MEDI 61 ACAPODENE TM 61 GW# [003] 61 recurrent glioblastoma 61 EP #R 61 IMC #F# 61 Pegloticase 61 IRX 2 61 JAK inhibitor 61 tezampanel 61 PrevOnco 61 TLR9 agonist 60 Thiarabine 60 successfully commercialize Iluvien 60 Pitavastatin 60 Cloretazine ® 60 Phase Ib II 60 refractory NSCLC 60 Peginterferon alfa 2b 60 Tasimelteon 60 generation Hsp# inhibitor 60 Sym# 60 aerosolized AAT 60 unresectable locally advanced 60 biologic therapeutics 60 oral ridaforolimus 60 entinostat 60 Xeloda capecitabine 60 GV# [001] 60 tumors GIST 60 humanised monoclonal antibody 60 metastatic sarcomas 60 ELACYT 60 Spiegelmer ® 60 Pafuramidine 60 LHRH receptor positive 60 phase IIb trial 60 imatinib Gleevec ® 60 Personalized Immunotherapy 60 vemurafenib 60 FOLOTYN ® 60 candidate TNFerade biologic 60 Vicriviroc 60 Solorel TM 60 GLP toxicology studies 60 Phase Ib IIa 60 ruxolitinib 60 Seliciclib 60 otelixizumab 60 Voreloxin 60 protein tyrosine phosphatase 1B 60 delivers fluocinolone acetonide FA 60 erlotinib Tarceva ® 60 MYDICAR ® 60 MKC# MT 60 CCX# 60 SURFAXIN r 60 Litx 60 HGS ETR2 60 lumiliximab 60 M# rationally 60 HuMax EGFr 60 antisense drug 60 adipiplon 60 HuCAL antibodies 60 PNP inhibitor 60 PI3K inhibitor 60 CA9 SCAN 60 Pancreate 60 GSK '# 60 Campath ® 60 PF # [002] 60 SCIB1 60 protein kinase inhibitor 60 kidney urologic 60 Kahalalide F 60 Zoraxel TM 60 HuMax TAC 60 either acutely decompensated 60 biliary tract cancer 60 HQK 60 trastuzumab Herceptin R 60 Lixivaptan 60 Troxatyl TM 60 OvaRex 60 zanolimumab 60 PHX# 60 Presents Preclinical Data 60 aldehyde dehydrogenase ALDH2 deficiency 60 personalized dendritic 60 Cloretazine 60 nucleotide analog 60 adecatumumab MT# 60 Epothilone D 60 thalidomide Thalomid 60 TELINTRA 60 davunetide intranasal AL 60 gefitinib Iressa 60 VitiGam 60 Targeted Chemotherapy 60 Endotis 60 cilengitide 60 molecular imaging radiopharmaceuticals 60 cystinosis patients 60 Alfacell proprietary ribonuclease 60 ulimorelin 60 hormone LHRH antagonist 60 GMX# 60 Omacetaxine 60 evaluating picoplatin 60 GVAX ® 60 cannabinor 60 Tarvacin Anti Cancer 60 Zybrestat 60 IGF 1R inhibitor 60 Potelligent Technology 60 Poly ICLC 60 EOquin TM 60 Triapine 60 IMPDH inhibitor 60 oral salmon calcitonin 60 Multimeric 60 OMAPRO 60 demonstrated antitumor activity 60 MTP inhibitor 60 R sorafenib tablets 60 Phase #b/#a clinical 60 Bezielle 60 midstage clinical 60 eritoran 60 pharmacological chaperone 60 novel oral anticoagulant 60 nasal spray formulation 60 NeuVax 60 Micromet BiTE 60 elacytarabine 60 elvucitabine 59 telomerase activator 59 PGL# 59 OHR/AVR# 59 ENMD # 59 vascular disrupting agent 59 Capesaris 59 Prodarsan R 59 telomerase therapeutic 59 Hsp# Inhibitor 59 VersaFilm 59 OMNARIS HFA 59 tumor vascular disrupting 59 aflibercept VEGF Trap 59 Marqibo TM 59 multi kinase inhibitor 59 elotuzumab 59 virus HCV protease inhibitor 59 Bicifadine 59 CRLX# 59 bortezomib Velcade 59 recombinant enzyme 59 Crizotinib 59 CCR5 antagonist 59 oral PTH 59 molecular imaging radiopharmaceutical 59 hypoxia activated prodrug 59 Janus Kinase 59 Hsp# inhibition 59 Src inhibitors 59 selective agonist 59 ALK inhibitors 59 acetonide FA 59 DP b# 59 Hemopurifier ® 59 regorafenib 59 Zalypsis 59 XmAb# 59 gemcitabine Gemzar ® 59 YONDELIS R 59 IMC #B 59 Meets Primary Endpoint 59 PORxin TM platforms 59 candidate CRLX# 59 docetaxel Taxotere ® 59 signal transduction inhibitor 59 generation PNP inhibitor 59 DPP4 inhibitor 59 TNF alpha antagonist 59 romazarit 59 topical gel containing 59 BRAF inhibitors 59 targeting CD# 59 neuronal nicotinic receptor NNR 59 CINQUIL 59 Nektar proprietary 59 Spiegelmer 59 Sanvar R 59 investigational monoclonal antibody 59 dexanabinol 59 histone deacetylase inhibitor 59 MKC# MKC# PP 59 baminercept 59 SPC# [001] 59 enzastaurin 59 maximally tolerated lipid lowering 59 candidate AQ4N 59 immune modulating 59 stated Michelle Berrey 59 Lupuzor 59 Intravail ® 59 cetuximab Erbitux R 59 anticancer compound 59 vascular disrupting agents 59 plasma kallikrein inhibitor 59 Phase 1b trial 59 Sapacitabine 59 MT#/MEDI-# 59 oral Hsp# inhibitor 59 Fx #A 59 RNA antagonists 59 Civacir 59 MAXY VII 59 ® bortezomib 59 Symadex 59 highly selective inhibitor 59 haematological cancers 59 Anticalin 59 VDAs 59 alkylating agent 59 Ophena 59 oncolytic 59 metastatic gastric 59 dimebon latrepirdine 59 rhIGF-I/rhIGFBP-3 59 apoptosis inducer 59 novel immunomodulatory 59 small molecule activators 59 Canvaxin TM 59 CTAP# Capsules 59 BENLYSTA ® 59 potent suppressor 59 Amrubicin 59 novel histone deacetylase 59 Achieves Primary Endpoint 59 GRNVAC1 59 Aganocide ® 59 RTP #i 59 retinal vein occlusion induced 59 lymphoid malignancies 59 FOLFOX6 chemotherapy regimen 59 humanized antibody 59 SERMs 59 Panzem 59 Lu AA# 59 trastuzumab DM1 T DM1 59 corticosteroid dexamethasone 59 oral antiviral 59 Akt inhibitor 59 pharmacodynamic properties 59 orally dosed 59 HepeX B 59 metastatic colorectal carcinoma 59 Resten NG 59 human antibody therapeutics 59 YONDELIS 59 Ceflatonin R 59 Maribavir 59 preclinically 59 VIBEX MTX 59 TG# [003] 59 Ixempra 59 Myocet 59 MKC# 59 VNP#M 59 Elotuzumab 59 Ophena TM 59 recombinant factor VIIa 59 oral ghrelin agonist 59 TG# [001] 59 Proellex TM 59 PRTX 59 BARACLUDE R 59 alpha folate receptor 59 PEGylated 59 fusion enhancers 59 Alocrest 59 ChronVac C R 59 Solazed 59 systemic RNAi 59 pegylated liposomal doxorubicin 59 solanezumab 59 orally inhaled migraine 59 metastatic hormone refractory 59 JAK#/JAK# 59 EndoTAGTM 1 59 metastatic CRC 59 Tarceva TM 59 BrachySil ™ 59 FOLFOX chemotherapy 59 Provectus Pharmaceuticals specializes 59 AERx iDMS 59 LB# [003] 59 ThermoDox R 59 targeted antifolate 59 Iluvien ® 59 telaprevir VX 59 maximally tolerated dose 59 registrational trial 59 potent topoisomerase II 59 relapsed multiple myeloma 59 BRIM2 59 HIV coinfected 59 humanized monoclonal antibody 59 Syncria 59 nalbuphine ER 59 Fleximer 59 forodesine hydrochloride 59 indibulin 59 Initiates Enrollment 59 hypoxia selective 59 novel peptide 59 ATL# [001] 59 IMiDs ® compound 59 immunotherapeutic vaccine 59 molecular chaperone regulation 59 CD# antibody [001] 59 Pradefovir 59 peptide conjugated 59 Novolimus 59 oral nucleoside analogue 59 TH# [003] 59 Nexavar sorafenib 59 intravesical instillation 59 polymerase inhibitor 59 Proquin XR 59 cMET 59 relapsed MM 59 pradefovir 59 sorafenib Nexavar 59 mGluR5 antagonists 59 pharmacokinetic PK study 59 Oral NKTR 59 Ambrisentan 59 Exherin 58 EDEMA3 58 triphendiol 58 antiangiogenic agent 58 Fludara ® 58 induced macular edema 58 aerosolized KL4 surfactant 58 tubulin inhibitor 58 pegylated recombinant 58 Safinamide 58 immunosuppressant therapies 58 commercialize deforolimus 58 lomitapide 58 Neuvenge 58 anti angiogenic drugs 58 lixivaptan 58 non nucleoside 58 Juvantia 58 NEUVENGE 58 engineered anticoagulant 58 ProSavin 58 interferon beta therapy 58 novel topoisomerase 58 MORAb 58 Kinase Inhibitor 58 PEG SN# 58 sulfonylhydrazine class 58 LHRH antagonist 58 novel immunotherapeutic 58 Copegus ribavirin 58 depsipeptide 58 IL# PE#QQR 58 anionic backbone 58 candidate Zelrix 58 CD# CEA 58 Pentad TM 58 torezolid phosphate 58 metastatic renal cell carcinoma 58 delivery polymer matrix 58 Kamada AAT 58 Cx# [002] 58 mGluR5 NAM 58 Prodarsan ® 58 ZFP Therapeutics 58 velafermin 58 synthetic anthracycline 58 Ganciclovir 58 midstage trials 58 assessing T DM1 58 TLK# 58 Selective Electrochemical Tumor Ablation 58 small molecule glucokinase 58 sapacitabine CYC# 58 radezolid 58 ACAPODENE 58 mda 7 58 Cloretazine R VNP#M 58 XP# XP# 58 monoclonal antibody MAb 58 Onno van de Stolpe 58 Temsirolimus 58 Bayer HealthCare Onyx Pharmaceuticals 58 Cyclosert TM 58 SNT MC# 58 oxaliplatin Eloxatin 58 Difimicin 58 Cinquil 58 Aclidinium 58 photoprotective drug 58 Alnylam RNAi 58 Vitaxin 58 urocortin 2 58 CCX# B 58 Tykerb lapatinib 58 LE DT 58 Exelixis compounds 58 adefovir dipivoxil 58 HCV NS5B polymerase 58 compound AEOL # 58 Xcellerated T Cells 58 Desmoteplase 58 hematological malignancy 58 selective modulator 58 aleglitazar 58 sterile lidocaine patch 58 PI3K/mTOR 58 epigenetic therapies 58 trastuzumab DM1 58 RAV# 58 angiogenesis inhibitor 58 incyclinide 58 PDE4 inhibitors 58 Abbokinase 58 Octreolin 58 mitogen activated ERK kinase 58 TRAIL receptor antibodies 58 AQ4N 58 imexon 58 MVA BN R 58 dermatology biopharmaceutical company 58 Tumour Vascular Disrupting Agent 58 inhibitor RG# 58 oral opioid modulator 58 metastatic bladder 58 TroVax ® 58 Genentech Rituxan 58 Albuferon TM 58 HCV protease 58 oral Janus kinase 58 mitoxantrone plus 58 transdermal gel 58 class anticancer quinolone 58 selective inverse agonist 58 patented Bioral 58 cancer neuroendocrine tumor 58 dutogliptin 58 histone deacetylase HDAC inhibitor 58 Pertuzumab 58 MAXY G# 58 Plicera 58 humanised antibody 58 DEEP AF 58 nanopharmaceutical 58 Xeloda ® 58 Aplidin R 58 Initiates Clinical Trial 58 Zysolin TM 58 Pharmacokinetics PK 58 LEUKINE 58 IIa trial 58 MNTX 58 Initiates Clinical 58 Tesmilifene 58 immune modulatory 58 MCSP respectively 58 histone deacetylase HDAC 58 selective A2A adenosine receptor 58 DEB# 58 metastatic colorectal 58 Aurora Kinase 58 accumulate preferentially 58 Luteinizing Hormone Releasing Hormone 58 Urocidin 58 Pruvel ™ 58 favorable pharmacokinetic profile 58 PEGylated anti 58 PI3K inhibitors 58 stage antibody MT# 58 VitiGam TM 58 inhaled liposomal ciprofloxacin 58 Ketotransdel 58 Darusentan 58 vosaroxin 58 TOCOSOL 58 pertuzumab 58 GED aPC 58 Panzem R 58 Pruvel TM 58 PEG IFN 58 recurrent NSCLC 58 siRNA therapeutic 58 fosbretabulin 58 PRLX # 58 Maxy G# 58 PDX pralatrexate 58 Orally administered 58 BEMA TM Fentanyl 58 Memryte 58 tranilast 58 Isis antisense 58 markets Testim ® 58 TKM PLK1 58 miconazole Lauriad ® 58 ATL/TV# 58 NS5b 58 CCR5 inhibitor 58 cancer immunotherapies 58 Laquinimod 58 Optiquel ™ 58 investigational HCV polymerase 58 Pathway Inhibitor 58 SinuNase ™ 58 selective estrogen receptor modulator 58 ZACTIMA 58 EGS# 58 TNF Tumor Necrosis Factor 58 Ventavis ® 58 telomerase inhibitor drug 58 zotarolimus 58 Elagolix 58 opioid bowel dysfunction 58 injectable formulation 58 SUTENT ® 58 humanized monoclonal antibodies 58 Olaparib 58 CRTH2 58 ProLindac TM 58 Squalamine 58 tolevamer 58 PTK# 58 PresbyLens ® 58 MyVax ® 58 Zavesca r 58 multitargeted 58 adrenergic regulation 58 developing TB4 58 pegylated interferons 58 novel emulsion formulation 58 OXi# 58 pharmacogenomic translational research 58 BiTE antibody 58 Initiate Clinical Trial 58 taxane resistant 58 FVIIa 58 Vernakalant 58 Intarcia 58 bevacizumab Avastin ® 58 pegylated interferon alfa 2a 58 #D#C# 58 virosome 58 nicotinic alpha 7 58 platinum chemotherapeutic 58 catheter occlusion 58 novel anticancer 58 motesanib 58 novel synthetic peptide 58 huN# DM1 58 Nanobodies ® 58 thrombin component 58 Viramidine 58 Vascular Disrupting Agent 58 DXL# 58 Romidepsin 58 selective kinase inhibitors 58 Junovan TM 58 galiximab 58 initiated Phase Ib 58 Zemiva TM 58 development peramivir neuraminidase 58 ADI PEG 58 subcutaneous SC 58 Smac mimetic 58 Pralatrexate 58 VAPRISOL 58 Allovectin 7 ® 58 Alexza Staccato 58 EVIZON ™ 58 ABL inhibitor 58 PEGylated irinotecan 58 Tyrima 58 pharmacokinetic interactions 58 HDL Selective Delipidation 58 albiglutide 58 Fibrin Pad 58 ularitide 58 intranasal delivery 58 rifalazil 58 Bioral Amphotericin B 58 dasatinib Sprycel ® 57 triggers apoptosis programmed 57 E1 INT TM 57 relapsed refractory multiple myeloma 57 novel antiviral therapeutics 57 glatiramer 57 teriflunomide 57 Pfizer Camptosar 57 talactoferrin 57 oral Azacitidine 57 metastatic HRPC 57 Phase 2b clinical trials 57 2 methoxyestradiol 57 oxidative stress inducer 57 small molecule Hedgehog 57 progressive metastatic prostate 57 aromatase inhibitor AI 57 nitric oxide donating prostaglandin 57 EndoTAG TM -1 57 DCVax R 57 diabetic neuropathic pain 57 preclinical efficacy 57 CEQ# 57 TransVax tm 57 ceftazidime 57 thetreatment 57 kinase inhibitor 57 stable nucleic acid 57 NV1FGF 57 prostone 57 Apo AIMilano 57 ZEVALIN ® 57 xanthine oxidase inhibitor 57 afamelanotide 57 Omnitarg 57 Aviptadil 57 treatment naïve genotype 57 rindopepimut 57 Elvitegravir 57 apricitabine ATC 57 choroidal vasculopathy 57 gemcitabine carboplatin 57 HuLuc# 57 Submits IND 57 ALN HTT 57 phase IIa clinical 57 Dalbavancin 57 DDP# 57 neurology immunology 57 virus AAV 57 castrate resistant prostate cancer 57 OXIGON TM 57 pharmacokinetic equivalence 57 Cloretazine R 57 irreversible inhibitor 57 statistically significant efficacy 57 allogeneic cell 57 trabectedin 57 concurrent chemoradiation 57 mTOR inhibitor 57 BrachySil 57 personalized dendritic cell 57 advanced unresectable 57 taxane derivative 57 ALN PCS 57 Genz # 57 ESBA# 57 Cand5 57 Nexavar sorafenib tablets 57 refractory metastatic colorectal cancer 57 antimitotic 57 immatics 57 IMiD 57 JAK2 inhibitors 57 eniluracil 57 NPC 1C 57 oral proteasome inhibitor 57 TM Aganocide 57 Scancell 57 MyVax personalized immunotherapy 57 Survivin antagonist 57 rALLy 57 UVIDEM 57 LHRH antagonists 57 Solulin 57 myelodysplastic myeloproliferative diseases 57 MAXY alpha 57 L Annamycin 57 orally disintegrating 57 NeoLipid TM 57 Adnectin 57 vapreotide acetate 57 MET amplification 57 treat chronic sinusitis 57 MOVIPREP R 57 polymerase inhibitors 57 BCR ABL inhibitor 57 ReN# 57 targeting PCSK9 57 oral taxane 57 Cetrorelix 57 TLR agonists 57 hepatitis C protease inhibitor 57 pain palliation 57 Clevudine 57 interferon gamma 1b 57 Gleevec imatinib mesylate 57 candidates Azedra TM 57 Onalta TM 57 LBH# 57 Aganocide 57 Vaccinex 57 TNF alpha inhibitor 57 CytoFab ™ 57 Phase #/#a 57 cabozantinib 57 diagnostic biomarker 57 ALTROPANE R 57 oncolytic virus therapy 57 Cannabinor 57 intravenous AAT 57 rALLy clinical trial 57 taxane chemotherapy administered 57 hematologic tumors 57 apomorphine hydrochloride 57 cetuximab Erbitux 57 recombinant biopharmaceutical 57 CB2 selective 57 antifolates 57 pralatrexate 57 oral Factor Xa 57 anti angiogenic therapy 57 renin inhibitor 57 pegylated interferon alpha 2a 57 superficial bladder cancer 57 tiapamil 57 NEUGENE R 57 defensin mimetic antibiotic 57 Specifid 57 delta opioid receptor 57 Anticalin R 57 compound INCB# 57 BNC# 57 Panitumumab 57 Allovectin 7 R 57 irinotecan doxorubicin oxaliplatin paclitaxel 57 anti angiogenic agents 57 Nanobody R 57 Quinamed 57 Anticalins R 57 Preclinical studies suggest 57 Evoltra ® 57 DepoBupivacaine TM 57 telomerase inhibitor 57 oral renin inhibitor 57 topoisomerase II inhibitor 57 Nexavar ® 57 Anti VEGF 57 BioFocus DPI Galapagos 57 siRNA therapeutics 57 sorafenib tablets 57 alpha#beta# integrin 57 investigational oral hepatitis C 57 RezularTM 57 miconazole Lauriad 57 Arikace 57 PXD# 57 NS#/#A protease 57 SEPET TM 57 topical gel formulation 57 ART# 57 Vidaza azacitidine 57 RhuDex R